Obstructive sleep apnoea: A diabetologist's perspective

Abd A. Tahrani*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)
184 Downloads (Pure)


Obstructive sleep apnoea (OSA) is very common in patients with type 2 diabetes (T2D), which is unsurprising given that obesity is a major risk factor for both conditions. OSA has been associated with impaired quality of life, many cardiovascular disease (CVD) risk factors and cardiovascular disease in general. Continuous positive airway pressure treatment has beneficial impacts on CVD risk factors and CVD. However, the true impact of OSA in patients with T2D remains unclear. The International Diabetes Federation recommended routine screening for OSA in patients with T2D, but two-thirds of diabetes healthcare professionals were unaware of these recommendations. The aim of this review is to attempt to answer the following questions. Is OSA diagnosis and treatment important in patients with T2D and why? What is the relevance of OSA to the practising diabetologist?.

Original languageEnglish
Pages (from-to)107-113
Number of pages7
JournalThe British Journal of Diabetes & Vascular Disease
Issue number3
Publication statusPublished - 1 Jul 2016


  • Cardiovascular disease
  • Hyperlipidaemia
  • Hypertension
  • Obstructive sleep apnoea
  • Quality of life
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Obstructive sleep apnoea: A diabetologist's perspective'. Together they form a unique fingerprint.

Cite this